Y. Souteyrand

发表

The WHO public-health approach to antiretroviral treatment against HIV in resource-limited settings

S. Gove, C. Gilks, Marco Vitoria, 2006, The Lancet.

Evaluation of Three Sampling Methods to Monitor Outcomes of Antiretroviral Treatment Programmes in Low- and Middle-Income Countries

F. Dabis, D. Bennett, A. Harries, 2010, PloS one.

Free care at the point of service delivery: a key component for reaching universal access to HIV/AIDS treatment in developing countries

J. Moatti, Y. Souteyrand, T. Guerma, 2008, AIDS.

Leveraging Global Fund investments for health systems strengthening: a qualitative case study on Morocco's Concept Note development.

K. Alami, Y. Souteyrand, V. Mangiaterra, 2020, Eastern Mediterranean health journal = La revue de sante de la Mediterranee orientale = al-Majallah al-sihhiyah li-sharq al-mutawassit.

TO RETAIN OR REMOVE USER FEES ? Reflections on the current debate 1 TO RETAIN OR REMOVE USER FEES ? Reflections on the current debate

B. Meessen, S. Morris, D. Balabanova, 2006 .

Antiretroviral therapy needs: the effect of changing global guidelines

K. Stanecki, Jesus M Garcia Calleja, J. Stover, 2010, Sexually Transmitted Infections.

Trends in Retention on Antiretroviral Therapy in National Programs in Low-Income and Middle-Income Countries

J. Tassie, S. Crowley, Y. Souteyrand, 2010, Journal of acquired immune deficiency syndromes.

HIV Epidemic and Response: Social, Economic and Development Impact

Y. Souteyrand, Dongbao Yu, Kerry A. Kutch, 2009 .

Derivation of parameters used in Spectrum for eligibility for antiretroviral therapy and survival on antiretroviral therapy

F. Dabis, C. Lewden, M. Mahy, 2010, Sexually Transmitted Infections.

Expanding access to antiretroviral therapies in Chile: economic and financial issues for patients and the health system.

Y. Souteyrand, C. Morales, C. CidPedraza, 2003 .

Investment in HIV/AIDS programs: Does it help strengthen health systems in developing countries?

J. Kaufman, Y. Souteyrand, J. Perriëns, 2008, Globalization and health.

National adult antiretroviral therapy guidelines in resource-limited countries: concordance with 2003 WHO guidelines?

C. Gilks, E. Beck, S. Mandalia, 2006, AIDS.

Changes in antiretroviral therapy guidelines: implications for public health policy and public purses

J. Garcia-Calleja, C. Gilks, K. D. de Cock, 2010, Sexually Transmitted Infections.

Impact of contact tracing, respect of isolation, and lockdown in reducing the number of cases infected with COVID-19. Case study: Tunisia’s response from March 22 to May 4, 2020

M. Hsairi, H. Romdhane, O. Saidi, 2021, International Journal of Infectious Diseases.

Expanding ART for Treatment and Prevention of HIV in South Africa: Estimated Cost and Cost-Effectiveness 2011-2050

J. Kahn, B. Williams, R. Granich, 2012, PloS one.

Harnessing the Prevention Benefits of Antiretroviral Therapy to Address HIV and Tuberculosis

C. Obermeyer, J. Montaner, J. Kahn, 2011, Current HIV research.

Integrated surveillance of HIV care in low-income and middle-income countries

J. Tassie, Y. Souteyrand, S. Bertagnolio, 2011, Current opinion in HIV and AIDS.

Highly active antiretroviral treatment as prevention of HIV transmission: review of scientific evidence and update

J. Kahn, B. Williams, R. Granich, 2010, Current opinion in HIV and AIDS.

Highly active antiretroviral treatment for the prevention of HIV transmission

C. Dye, C. Gilks, K. D. de Cock, 2010, Journal of the International AIDS Society.

HIV/AIDS social and behavioural research: past advances and thoughts about the future.

J. Moatti, Y. Souteyrand, Yves Souteyrand, 2000, Social science & medicine.

Harnessing the secondary preventive benefit of antiretroviral treatment

J. Montaner, J. Kahn, B. Williams, 2010 .

Beyond Indicators: Advances in Global HIV Monitoring and Evaluation During the PEPFAR Era

Mindy Hochgesang, Bobby Jefferson, Dimitri Prybylski, 2012, Journal of acquired immune deficiency syndromes.

Economics of AIDS and access to HIV-AIDS care in developing countries: issues and challenges

J. Moatti, B. Coriat, T. Barnett, 2003 .

Estimation of antiretroviral therapy coverage: methodology and trends

P. Ghys, M. Mahy, J. Stover, 2010, Current opinion in HIV and AIDS.

Patents generic drugs and the markets for antiretrovirals.

J. Moatti, B. Coriat, T. Barnett, 2003 .

Universal access to anti-HIV therapy

Y. Souteyrand, 2012, Retrovirology.

Baseline Seroprevalence of SARS-CoV-2 Specific Antibodies in Hot Spot Areas of Great Tunis, up to 3 Months Post Disease Onset in Tunisia

S. Dhaouadi, Nissaf Bouafif ép Ben Alaya, P. Nabeth, 2023, Epidemiologia.

Financing efficient HIV care and antiretroviral treatment to mitigate the impact of the AIDS epidemic on economic and human development

J. Moatti, B. Coriat, T. Barnett, 2003 .

Has the quality of serosurveillance in low- and middle-income countries improved since the last HIV estimates round in 2007? Status and trends through 2009

E. Gouws, K. Sabin, Jesus M Garcia Calleja, 2010, Sexually Transmitted Infections.

Utilization Patterns and Projected Demand of Antiretroviral Drugs in Low- and Middle-Income Countries

C. Ávila-Figueroa, J. Stover, Y. Souteyrand, 2011, AIDS research and treatment.

Investment in HIV/AIDS programs: Does it help strengthen health systems in developing countries?

Y. Souteyrand, Mazuwa Banda, Dongbao Yu, 2008, Globalization and health.